「with the」の検索結果
86件：1～5件目を表示
-
製品開発方針 | 研究開発活動 | 千寿製薬株式会社
s T, et al. RNA-Seq-based transcriptome analysis of corneal endothelial cells derived from patients with Fuchs endothelial corneal dystrophy. Sci Rep. 2023;13(1):8647. #6: Krachmer JH, Purcell JJ Jr,...
https://www.senju.co.jp/rd/policy/ -
nju is committed to obtaining marketing approval for the DED treatment SJP-0132 to provide patients with new options for alleviating the signs and symptoms of this disease. Mochida is dedicated to lev...
https://www.senju.co.jp/system/files/content_news/2024-07/ENG_20240716.pdf -
arpening algorithm. We aim to promote “more visibility” by providing products and services equipped with image sharpening and high-resolution algorithms in the future, emphasizing the importance of si...
https://www.senju.co.jp/system/files/content_news/2024-04/ENG_20240423_0.pdf -
千寿製薬株式会社
formulation of Aibeta® combination eye drops（PDF） March 7, 2025 Announcement of Licensing Agreement with Brill International（PDF） February 20, 2025 Launch and Distribution of “MIEr for BeelineMED”（PDF...
http://www.senju.co.jp/english/ -
nju is committed to obtaining marketing approval for the DED treatment SJP-0132 to provide patients with new options for alleviating the signs and symptoms of this disease. Mochida is dedicated to lev...
https://www.senju.co.jp/system/files/content_news/2024-07/ENG_20240716_0.pdf